SCHEMBL29614639

SCHEMBL29614639

COC(=O)c1cc(N2CCC(CO)CC2)ccc1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
ALDH1A1 P00352 2/20 0.43
SIRT6 Q8N6T7 1/20 0.42
HTR6 P50406 2/20 0.41
LRRK2 Q5S007 1/20 0.41
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
KDM4E B2RXH2 2/20 0.40
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
PRKDC P78527 1/20 0.38
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
OPRK1 P41145 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24421376 1.00 BRD4 (0.44) BRD4ALDH1A1SIRT6HTR6LRRK2
SCHEMBL21876917 0.91 BRD4 (0.42) BRD4ALDH1A1SIRT6HTR6LRRK2
SCHEMBL27345173 0.84 KDM4E (0.43) BRD4ALDH1A1SIRT6HTR6KMT2A
SCHEMBL24207467 0.84 KDM4E (0.43) BRD4ALDH1A1SIRT6HTR6KMT2A
SCHEMBL27345174 0.84 KDM4E (0.43) BRD4ALDH1A1SIRT6HTR6KMT2A
SCHEMBL26648895 0.82 ALDH1A1 (0.42) ALDH1A1SIRT6HTR6KMT2AMEN1
SCHEMBL27239095 0.81 USP30 (0.48) ALDH1A1SIRT6HTR6LRRK2KMT2A
SCHEMBL26649385 0.80 CHRM4 (0.44) ALDH1A1SIRT6HTR6LRRK2KMT2A
SCHEMBL24421198 0.79 FFAR4 (0.39) ALDH1A1KMT2AMEN1KDM4ENPC1
SCHEMBL24421386 0.78 KMT2A (0.39) ALDH1A1SIRT6HTR6KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240743-A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE Prelude Therapeutics, Incorporated (US) 2023-09-13 EP disclosed
WO-2022099117-A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE PRELUDE THERAPEUTICS INCORPORATED (US) 2022-05-12 WO disclosed